5 IsoCord® (18 G x 20cm) needles for pre-loading seeds used for low dose brachytherapy for prostate cancer, in sealed packaging, made by BEBIG GBmH, an Eckert & Ziegler company, Berlin, Germany, 2017-2019

Each IsoCord® needle can hold up to 16 ‘seeds’ used in a cancer treatment known as low dose brachytherapy. To treat prostate cancer, 80 to 120 seeds, each as small a grain of rice, are placed in the body via long needles while a person has a general anaesthetic. Each needle has spacers to help with needle loading. By placing radioactive material into the prostate, cancerous cells are targeted while minimising the impact to health tissue. Each seed emits radiation of a radioisotope known as iodine-125 for up to a year. The IsoCord® system has been developed to make preparation of needles ready for implant safe and efficient.

Sealed demonstration example of a IsoSeed I-125 prostate brachytherapy seed, with no radioactive nucletides, made by BEBIG GBmH, an Eckert & Ziegler company, Berlin, Germany, 2017-2019

As small as a grain of rice, this is the type of ‘seed’ that is used in a cancer treatment known as low dose brachytherapy. To treat prostate cancer, 80 to 120 seeds are placed in the body via needles while a person has a general anaesthetic. By placing radioactive material into the prostate, cancerous cells are targeted while minimising the impact to healthy tissue. Each seed emits radiation of a radioisotope known as iodine-125 for up to a year. Fully visible under imaging techniques such as X-ray and CT, the IsoSeed I-125 is part of the IsoCord® system.

Demonstration model of the IsoCord® magazine, a transport container and a drive for the IsoCord® Seed Chain, with cardboard and plastic packaging, part of the IscoCord® prostate seed brachytherapy system made by BEBIG GBmH, an Eckert & Ziegler company, Berlin, Germany, 2017-2019

An IsoCord® magazine holds up to 60 radioactive ‘seeds’ in chain with spacers and wrapped in suture material. These seeds are used in a cancer treatment known as low dose brachytherapy. To treat prostate cancer, 80 to 120 seeds, each as small a grain of rice, are placed in the body via long needles while a person has a general anaesthetic. The spacers and suture material are absorbed by the body. By placing radioactive material into the prostate, cancerous cells are targeted while minimising the impact to health tissue. Each seed emits radiation of a radioisotope known as iodine-125 for up to a year. The metal container acts as a transport container and is used with the Isocord® Needle Driver to help protect the person preparing the treatment.

Sterilisation tray (NLZ100) for IsoCord® accessories and Needle Loading Station, made by BEBIG GBmH, an Eckert & Ziegler company, Berlin, Germany, 2017-2019

Designed to fit all the parts of IsoCord® system, used to prepare a low dose treatment for prostate cancer, the tray and any accessories can be sterilised using steam. This means the kit can safely be re-used. The tray can also be used for storage.

The IsoCord® system uses ‘seeds’ that emit radiation for up to a year. In treating prostate cancer, the seeds are placed in the body via needles while a person has a general anaesthetic. By placing radioactive material into the prostate, cancerous cells are targeted while minimising the impact to health tissue. This type of cancer treatment is known as brachytherapy.

IsoCord® Needle Loading Station (NSL 101), serial number 209-15, used to prepare implantation needles with seeds for low dose brachytherapy for prostate cancer, with a plastic carry-case, made by BEBIG GBmH, an Eckert & Ziegler company, Berlin, Germany, 2017-2019

Designed to make preparing a low dose cancer treatment known as brachytherapy efficient and as safe as possible this device known as IsoCord® Needle Loading Station adds radioactive ‘seeds’ into needles so they can be implanted. To treat prostate cancer, 80 to 120 seeds, each as small a grain of rice, are placed in the body via long needles while a person has a general anaesthetic. By placing radioactive material into the prostate, cancerous cells are targeted while minimising the impact to health tissue. Each seed emits radiation of a radioisotope known as iodine-125 for up to a year. It is fully sterilisable by steam so it can be safely reused. It also includes a cutting tool so the IsoSeed® chain held in the magazine can be cut to size.